CASTLE BIOSCIENCES INC
CSTLUS売上高
$344M
百万USD
営業利益
$-43M
百万USD
純利益
$-24M
百万USD
ROE
-5.1%
最新FY
EPS
$-0.83
USD / 株
配当
$0.00
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $23M | $-4M | $-0.17 |
| FY2021 | Q2 | $23M | $-9M | $-0.35 |
| FY2021 | Q3 | $23M | $-12M | $-0.47 |
| FY2021 | FY | $94M | $-31M | $-1.24 |
| FY2022 | Q1 | $27M | $-25M | $-0.97 |
| FY2022 | Q2 | $35M | $-2M | $-0.06 |
| FY2022 | Q3 | $37M | $-20M | $-0.77 |
| FY2022 | FY | $137M | $-67M | $-2.58 |
| FY2023 | Q1 | $42M | $-29M | $-1.10 |
| FY2023 | Q2 | $50M | $-19M | $-0.70 |
| FY2023 | Q3 | $61M | $-7M | $-0.26 |
| FY2023 | FY | $220M | $-57M | $-2.14 |
| FY2024 | Q1 | $73M | $-3M | $-0.09 |
| FY2024 | Q2 | $87M | $9M | $0.31 |
| FY2024 | Q3 | $86M | $2M | $0.08 |
| FY2024 | FY | $332M | $18M | $0.62 |
| FY2025 | Q1 | $88M | $-26M | $-0.90 |
| FY2025 | Q2 | $86M | $5M | $0.15 |
| FY2025 | Q3 | $83M | $-1M | $-0.02 |
| FY2025 | FY | $344M | $-24M | $-0.83 |
| FY2026 | Q1 | $84M | $-15M | $-0.49 |
財務データ
| 指標 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| 売上高 | $52M | $63M | $94M | $137M | $220M | $332M | $344M |
| 営業利益 | $7M | $-7M | $-40M | $-73M | $-68M | $9M | $-43M |
| 純利益 | $5M | $-10M | $-31M | $-67M | $-57M | $18M | $-24M |
| 総資産 | $120M | $439M | $463M | $447M | $453M | $531M | $579M |
| 純資産 | - | - | - | - | - | - | - |
| 自己資本 | $85M | $416M | $412M | $399M | $391M | $456M | $471M |
| 営業CF | $7M | $10M | $-19M | $-42M | $-6M | $65M | $64M |
| EPS | $-0.21 | $-0.54 | $-1.24 | $-2.58 | $-2.14 | $0.62 | $-0.83 |
| BPS | $4.95 | $16.64 | $16.20 | $15.02 | $14.25 | $15.99 | $15.84 |
| ROE | 6.2% | -2.5% | -7.6% | -16.8% | -14.7% | 4.0% | -5.1% |